Naxogen (nitrimidazine) in giardiasis.
D000293:Adolescent; D000328:Adult; D000981:Antiprotozoal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D005260:Female; D005873:Giardiasis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000009:adverse effects / Q000627:therapeutic use; D009593:Nitroimidazoles / Q000009:adverse effects / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D009025:Morpholines; D009593:Nitroimidazoles